International Stem Cell Corporation , a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells today announced positive results demonstrating the safety and efficacy of stem cell engraftment in a primate model of Parkinson's disease.
http://www.biospace.com/news_story.aspx?StoryID=291093&full=1
http://www.biospace.com/news_story.aspx?StoryID=291093&full=1
No comments:
Post a Comment